| Home | E-Submission | Sitemap | Contact us |  
Korean J Parasitol > Volume 26(1):1988 > Article

Original Article
Korean J Parasitol. 1988 Mar;26(1):65-68. English.
Published online Mar 20, 1994.  http://dx.doi.org/10.3347/kjp.1988.26.1.65
Copyright © 1988 by The Korean Society for Parasitology
Identification of Stellantchamus falcatus Metacercariae encysted in mullets in Korea
Jong Yil Chai and Woon Mok Sohn
Department of Parasitology and Institute of Endemic Diseases, College of Medicine, Seoul National University, Seoul 110-460, Korea.

A group of metacercariae encysted in the flesh of Mugil sp. were identified to be Stellantchasmus falcatus by the morphology of adult worms obtained experimentally. It is confirmed that mullets serve as a second intermediate host of this heterophyid fluke in Korea.

1. Africa CM, et al. Acta Med Philippina Monogr Ser 1940;1:1–132.
2. Alicata JE, et al. J Am Med Ass 1938;110(14):1100–1101.
3. Chen HT. Lingnan Sci J 1951;23:165–175.
4. Kagei N, et al. Jpn J Parasitol 1964;13(6):472–478.
5. Noda K. The larval development of Stellantchasmus falcatus (Trematoda: Heterophyidae) in the first intermediate host. J Parasitol 1959;45:635–642.
6. Onji Y, et al. Chiba Igakkai Zasshi 1924;2(3):113–161.
7. Pearson JC. A Revision Of The Subfamily Haplorchinae Looss, 1899 (Trematoda: Heterophyidae). I. The Haplorchis Group. Parasitology 1964;54:601–676.
8. Seo BS, Lee SH, Chai JY, Hong SJ. Studies on intestinal trematodes in Korea XII. Two cases of human infection by Stellantchasmus falcatus. Korean J Parasitol 1984;22(1):43–50.
9. Tantachamrun T, et al. Southeast Asian J Trop Med Publ Hlth 1978;9(2):43–50.
Editorial Office
Department of Molecular Parasitology, Samsung Medical Center, School of Medicine, Sungkyunkwan University,
2066 Seobu-ro, Jangan-gu, Suwon 16419, Gyeonggi-do, Korea.
Tel: +82-31-299-6251   FAX: +82-1-299-6269   E-mail: kjp.editor@gmail.com
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © 2022 by The Korean Society for Parasitology and Tropical Medicine.     Developed in M2PI